These subtypes including Luminal A, Luminal B, HER2-enriched, and triple-negative.[4] The treatment of breast cancer depends on different molecular subclasses, and its treatment pathways include local/regional interventions such as surgery and radiation therapy, as well as systemic therapy. Here, ERBB2 is linked to breast carcinoma.